SEC Form 25-NSE filed by Forward Pharma A/S

1/6/23 9:14:30 AM ET

$FWP

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $FWP alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36686

Issuer:	Forward Pharma A/S
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	Ostergade 24A, 1
	Copenhagen	DENMARK	1100
Telephone number:				45 3168 3110

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

American Depositary Shares

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2023-01-06	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $FWP alert in real time by email

SEC Form 25-NSE filed by Forward Pharma A/S

1/6/23 9:14:30 AM ET

$FWP

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $FWP alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36686

Issuer:	Forward Pharma A/S
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	Ostergade 24A, 1
	Copenhagen	DENMARK	1100
Telephone number:				45 3168 3110

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

American Depositary Shares

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2023-01-06	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $FWP alert in real time by email

SEC Form 25-NSE filed by Forward Pharma A/S

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$FWP

SEC Form 25-NSE filed by Forward Pharma A/S

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$FWP

$FWP
Press Releases

Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market

Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review

Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

$FWP
SEC Filings

SEC Form EFFECT filed by Forward Pharma A/S

SEC Form POS AM filed by Forward Pharma A/S

SEC Form S-8 POS filed by Forward Pharma A/S

$FWP
Large Ownership Changes

SEC Form SC 13G/A filed by Forward Pharma A/S (Amendment)

SEC Form SC 13G filed by Forward Pharma A/S

SEC Form SC 13G/A filed by Forward Pharma A/S (Amendment)

SEC Form 25-NSE filed by Forward Pharma A/S

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $FWP

SEC Form 25-NSE filed by Forward Pharma A/S

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $FWP

$FWP Press Releases

Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market

Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review

Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

$FWP SEC Filings

SEC Form EFFECT filed by Forward Pharma A/S

SEC Form POS AM filed by Forward Pharma A/S

SEC Form S-8 POS filed by Forward Pharma A/S

$FWP Large Ownership Changes

SEC Form SC 13G/A filed by Forward Pharma A/S (Amendment)

SEC Form SC 13G filed by Forward Pharma A/S

SEC Form SC 13G/A filed by Forward Pharma A/S (Amendment)

Recent Analyst Ratings for
$FWP

Recent Analyst Ratings for
$FWP

$FWP
Press Releases

$FWP
SEC Filings

$FWP
Large Ownership Changes